Glaxo’s Cervarix approved by EU

Author (Person)
Series Title
Series Details 25.9.07
Publication Date 25/09/2007
Content Type

European Union authorities approved on the 24 September 2007 the launch of Cervarix, GlaxoSmithKline's vaccine for cervical cancer, paving the way for competition with Gardasil, the rival product Merck launched Merckalmost one year ago.
Related Links
EMEA: Press Release, 25.7.07: Committee for Medicinal Products for Human Use:: Summary of positive opinion for Cervarix http://www.emea.europa.eu/pdfs/human/opinion/Cervarix_32215107en.pdf
EMA: Human medicines: European public assessment report: Cervarix http://www.emea.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000721/human_med_000694.jsp&mid=WC0b01ac058001d124
Subject Categories
Countries / Regions